Skip to content

Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology

Fuchs' Endothelial Dystrophy: Clinical Characteristics, Treatment Outcome, and Pathology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01979250
Enrollment
81
Registered
2013-11-08
Start date
2013-10-31
Completion date
2016-08-31
Last updated
2016-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fuchs' Endothelial Corneal Dystrophy

Keywords

endothelial keratoplasty, Descemet's stripping automated endothelial keratoplasty, lamellar keratoplasty

Brief summary

Background Fuchs' Endothelial Dystrophy Fuchs' Endothelial Dystrophy (Fuchs' ED) is characterized by changes on the inside of the cornea, which leads to a substantial decline in visual acuity. The only effective treatment option for Fuchs' ED is corneal transplantation. Corneal transplantation Corneal transplantation surgery has seen major advances in the last decade, and the Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) procedure has now become the preferred method. Outcome There have been a substantial number of publications on outcome after DSAEK surgery, and the procedure has several advantages over the former preferred method of transplantation, penetrating keratoplasty (PK). Despite the apparent success of the DSAEK procedure, visual acuity is seldom fully restored even in otherwise healthy eyes. Several studies have tried to clarify this matter but so far results have been conflicting. Hypotheses 1. The reduction in visual acuity and contrast sensitivity in patients with Fuchs' endothelial dystrophy is correlated with corneal thickness, corneal light scatter, and the type and magnitude of optical disrupting guttae in Descemet's membrane. 2. The subjective visual function after corneal transplantation with a posterior lamellar graft is correlated with the optical properties of the grafted cornea (thickness, light scatter, irregularities on the anterior, and posterior corneal surfaces) Materials and methods In a controlled prospective trial of DSAEK patients, we aim to register different morphological patterns, monitor visual performance and optical parameters. Three sex and age-matched groups will be compared: Group 1: 40 patients that undergo DSAEK surgery Group 2: 40 patients that undergo combined cataract and DSAEK surgery. Group 3: Control group of 40 patients with normal corneas that undergo cataract surgery.

Detailed description

Investigation outline: * Presence of the following patterns will be registered for each patient: Scattered guttae, confluent guttae, diffuse corneal oedema or confined corneal oedema * Refractive properties: Objective and subjective refraction * Visual performance: Visual acuity (ETDRS), Contrast sensitivity (FrACT method) * Corneal characterization: corneal sensibility (Cochet-Bonnet), In vivo confocal microscopy, specular microscopy, anterior segment OCT, OLCR, Pentacam with densitometry, and slit-lamp investigation will be performed. * Catquest 9SF questionnaire

Interventions

PROCEDUREDSAEK surgery

Corneal endothelial transplantation by Descemet's stripping automated endothelial keratoplasty (DSAEK).

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Fuchs' endothelial dystrophy * Candidate for DSAEK surgery

Exclusion criteria

* other ocular comorbidities that potentially limit vision or contrast vision

Design outcomes

Primary

MeasureTime frame
Visual acuityUp to 3 years

Other

MeasureTime frameDescription
Refractive properties, corneal clarity, subjective satisfactionUp to 3 yearsSubjective satisfaction will be measured using the Catquest 9SF questionnaire which uses a Likert scale which in turn is converted into a Rasch scale. The scales is linear, and uses a unit called the logit.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026